NCT07488884 2026-03-23
ResQ108B-PANC
ImmunityBio, Inc.
Phase 1 Not yet recruiting
Clinical Trials
11 trialsNCT07117032 2026-02-19
Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With Cancer-Related Celiac Pain
Case Comprehensive Cancer Center
Phase 1 Not yet recruiting
NCT06203821 2026-02-05
Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer
University of Rochester
Phase 1 Not yet recruiting
NCT06217666 2026-02-05
Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)
University of Rochester
Phase 1 Not yet recruiting
NCT07173374 2025-09-15
SCART-P
Shandong Cancer Hospital and Institute
Phase 1 Not yet recruiting
NCT06913218 2025-04-06
A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC
Akeso
Phase 1 Not yet recruiting
NCT06614751 2024-09-27
A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway
Danatlas Pharmaceuticals Co., Ltd
Phase 1 Not yet recruiting
NCT06549751 2024-08-12
PANACEA
Marker Therapeutics, Inc.
Phase 1 Not yet recruiting
NCT06346808 2024-04-04
Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC
Sichuan University
Phase 1 Not yet recruiting
NCT06134960 2023-11-18
NKG2D/CLDN18.21 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumor
Peking University
Phase 1 Not yet recruiting
NCT05361954 2023-04-12
Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors
Sorrento Therapeutics, Inc.
Phase 1 Not yet recruiting